PIMR and Pulmonary Vascular Disease
- Conditions
- Pulmonary Hypertension
- Interventions
- Other: Pulmonary Index of Microcirculatory ResistanceOther: Right Ventricle Index of Microcirculatory ResistanceOther: Pulmonary artery OCT
- Registration Number
- NCT05843461
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
The findings from this innovative, first-in-man, prospective pilot study will elucidate the role of PIMR and RV-IMR in pre-capillary PH. The study cohort will consist of patients with pulmonary pressures ranging from normal (advanced lung disease patients undergoing lung transplant evaluation) to severe PH (PAH and CTEPH patients), and thus will allow for identification of a PIMR cutoff. Participants will include: 1) advanced lung disease patients undergoing bilateral heart catheterization as part of their pre-lung transplant work-up, and 2) newly referred patients to PAH and CTEPH clinics undergoing bilateral heart catheterization as part of standard of care work-up. All participants will undergo PIMR testing, and those with pre-capillary PH will also undergo pulmonary OCT and measurement of RV-IMR. The study seeks to define the relationship between PIMR and PH and to establish the PIMR threshold that identifies pulmonary microvascular dysfunction as well as to evaluate the association of PIMR and pulmonary vascular remodeling on OCT in patients with pre-capillary PH. In addition, the study will assess the relationship between RV-IMR and RV pressure overload among patients with pre-capillary PH.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- ≥18 years old
- Able to provide informed written consent.
- Patients with 1) advanced lung disease requiring standard-of-care bilateral heart catheterization as part of lung transplant evaluation in whom mPAP < 20 mmHg on RHC, or 2) PAH/CTEPH (i.e. pre-capillary PH) undergoing standard-of-care bilateral heart catheterization as part of their work-up/treatment
- Contraindicated to undergo fluoroscopy and/or coronary angiography (e.g. pregnancy)
- Chronic kidney disease (serum creatinine ≥ 2.0 mg/dL)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description CTEPH Right Ventricle Index of Microcirculatory Resistance 10 patients with CTEPH CTEPH Pulmonary artery OCT 10 patients with CTEPH PAH Pulmonary artery OCT 10 patients with PAH Controls Pulmonary Index of Microcirculatory Resistance 10 patients without pulmonary hypertension (mean PA pressure less than 20 mmHg on RHC) PAH Pulmonary Index of Microcirculatory Resistance 10 patients with PAH PAH Right Ventricle Index of Microcirculatory Resistance 10 patients with PAH CTEPH Pulmonary Index of Microcirculatory Resistance 10 patients with CTEPH
- Primary Outcome Measures
Name Time Method Pulmonary Index of Microcirculatory Resistance (PIMR) Baseline PressureWire advanced to distal third of segmental pulmonary artery (PA) for measurement of pulmonary hemodynamics. The derivation of IMR involves the application of Ohm's law (V=IR) to the coronary microcirculatory circuit, where the relationship between resistance (R) = IMR, voltage (V) = pressure (P), and current (I) = flow (Q) can be expressed as follows: IMR = ∆P/Q. ∆P = the change in pressure across the microvasculature (mean distal coronary artery pressure \[Pd\] - coronary venous pressure (Pv); Pv is typically disregarded because it is negligible relative to Pd. Based on the principles of thermodilution, flow is inversely proportion to mean transit time (Q \~ 1/Tmn). Lastly, the minimal achievable resistance occurs during maximal hyperemic flow when all available microvessels have theoretically been recruited. Hence, the calculation of IMR simplifies to the following formula: IMR = Pd (pulmonary artery) x TmnHyp.
Right Ventricle Index of Microcirculatory Resistance (RV-IMR) Baseline PressureWire advanced to distal third of acute marginal branch of the right coronary artery (RCA) for measurement of pulmonary hemodynamics. The derivation of IMR involves the application of Ohm's law (V=IR) to the coronary microcirculatory circuit, where the relationship between resistance (R) = IMR, voltage (V) = pressure (P), and current (I) = flow (Q) can be expressed as follows: IMR = ∆P/Q. ∆P = the change in pressure across the microvasculature (mean distal coronary artery pressure \[Pd\] - coronary venous pressure (Pv); Pv is typically disregarded because it is negligible relative to Pd. Based on the principles of thermodilution, flow is inversely proportion to mean transit time (Q \~ 1/Tmn). Lastly, the minimal achievable resistance occurs during maximal hyperemic flow when all available microvessels have theoretically been recruited. Hence, the calculation of IMR simplifies to the following formula: IMR = Pd (RCA marginal branch) x TmnHyp.
OCT-derived thickness-diameter ratio Baseline A Dragonfly Optis OCT catheter (Abbott) will be advanced over the PressureWireX to the distal left lower lobe segmental pulmonary artery (luminal diameter \< 5 mm and minimal length of 50 mm). OCT images of the pulmonary artery will be recorded via automatic pullback and analyzed offline in a blinded manner.
OCT-derived pulmonary artery wall thickness Baseline A Dragonfly Optis OCT catheter (Abbott) will be advanced over the PressureWireX to the distal left lower lobe segmental pulmonary artery (luminal diameter \< 5 mm and minimal length of 50 mm). OCT images of the pulmonary artery will be recorded via automatic pullback and analyzed offline in a blinded manner.
OCT-derived wall-area ratio Baseline
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ronald Reagan UCLA Medical Center
🇺🇸Los Angeles, California, United States